Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Global Metagenomics Market Size study & Forecast, by Technology ( Shotgun Sequencing, 16S Sequencing, Whole Genome Sequencing and Others) by Product (Kits and Reagents, Sequencing & Data Analytics Services, Software), by Application ( Environmental Application, Clinical Diagnostics Applications, Drug Discovery Applications, Biotechnology Applications, Food & Nutrition Applications and Other Application), by Workflow (Pre-sequencing, Sequencing and Data Analysis) and Regional Analysis, 2022-2029
... Clinical Diagnostics Applications, Drug Discovery Applications, Biotechnology Applications, Food & Nutrition Applications and Other Application), by Workflow (Pre-sequencing, Sequencing and Data Analysis) and Regional Analysis, 2022-2029 Global Metagenomics Market is valued approximately USD 1.46 billion ... Read More
-
Global Stem Cells Market Size study & Forecast, by Product (Adult Stem Cells (ASCs), Human Embryonic Stem Cells (HESCs), Induced Pluripotent Stem Cells (iPSCs), Very Small Embryonic Like Stem Cells), By Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion and Sub-Culture), By Therapy (Autologous, Allogenic), By Application (Regenerative Medicine, Drug Discovery and Development), By End-user (Pharmaceutical and Biotechnology Companies, Hospitals & Cell Banks, Academic & Research Institutes), and Regional Analysis, 2022-2029
... Production, Cryopreservation, Expansion and Sub-Culture), By Therapy (Autologous, Allogenic), By Application (Regenerative Medicine, Drug Discovery and Development), By End-user (Pharmaceutical and Biotechnology Companies, Hospitals & Cell Banks, Academic & Research Institutes), and Regional Analysis, 2022-2029 ... Read More
-
DTP Vaccines Global Market Opportunities And Strategies To 2031
... need to assess the global DTP Vaccines market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering ... Read More
-
Global Seborrheic Keratosis Treatment Market Research Report 2022 - Market Size, Current Insights and Development Trends
... competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to ... Read More
-
Paroxysmal Nocturnal Hemoglobinuria (PNH) - Drug Pipeline Landscape, 2023
... Hemoglobinuria symptoms includes abdominal pain, back pain, dark urine, easy bruising or bleeding, headache, and shortness of breath. Paroxysmal Nocturnal Hemoglobinuria is diagnosed by tests like flow cytometry, a blood test that identifies blood cells ... Read More
-
Global Alzheimer Disease Treatment Market Research Report 2022 - Market Size, Current Insights and Development Trends
... competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to ... Read More
-
Microbiome Therapeutics: Global Markets
... Inc. Pylum Biosciences Inc. Quorum Innovations Llc Rebiotix Inc. (A Ferring Company) Second Genome Senda Biosciences Inc. Seres Therapeutics Inc. Sfa Therapeutics Inc. Synlogic Theriva Biologics Inc. Vedanta Biosciences Inc. Ysopia Bioscience Inc.Report Scope: BCC ... Read More
-
Virus-Like Particles (VLP’s) Market Analysis And Forecast To 2032: By Product Type (Hepatitis, Cancer/HPV, Gaucher Disease), Source (Yeast, Insect Cell, Plant, Others), Application (Vaccine, Therapeutics), And Region
... period. Virus-like particles (VLPs) are multiprotein structures that mimic the organization and conformation of authentic native viruses but lack the viral genome, potentially yielding safer and cheaper vaccine candidates. Market Trends and Drivers Consistent R&D ... Read More
-
Global Retinal Drugs Market 2023-2027
... on the retinal drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the ... Read More
-
Global Gastrointestinal Rare Diseases Treatment Market Growth (Status and Outlook) 2023-2029
... Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Gastrointestinal Rare Diseases Treatment sales for 2023 through 2029. With Gastrointestinal Rare Diseases Treatment sales broken down by region, market ... Read More
-
Global Soft Tissue Sarcoma Drugs Market Growth (Status and Outlook) 2023-2029
... Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Soft Tissue Sarcoma Drugs sales for 2023 through 2029. With Soft Tissue Sarcoma Drugs sales broken down by region, market ... Read More
-
Rare Disease Treatment Market Size By Drug (Biologics, Non-biologics), By Therapeutic Area (Cancer, Blood-related Disorders, Central Nervous System (CNS), Respiratory Disorders, Musculoskeletal Disorders, Cardiovascular Disorders), By Patient (Adult, Pediatric), By Route of Administration (Oral, Injectable), Industry Analysis Report, Regional Outlook, Growth Potential, Application Potential, Competitive Market Share & Forecast, 2023-2032
... Industry Analysis Report, Regional Outlook, Growth Potential, Application Potential, Competitive Market Share & Forecast, 2023-2032 Rare Disease Treatment Market is anticipated to grow considerably through 2032 owing to the increasing prevalence of rare diseases across ... Read More
-
Gastroesophageal Reflux Disease (GERD) - Drug Pipeline Landscape, 2023
... erosions. Gastroesophageal reflux disease can cause due to frequent acid reflux or reflux of nonacidic content from the stomach, If the sphincter does not relax as it should or it weakens, stomach acid can flow ... Read More
-
Frontal Fibrosing Alopecia
... Every MarketVue® includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable ... Read More
-
Ophthalmology Drugs Global Market Briefing 2023
... market was $7.2 and in terms of global GDP, the market was 0.05%. Ophthalmology drugs was the ninth largest segment within the market accounting for 3.5% preceded and followed by gastrointestinal drugs and at 4.7% ... Read More
-
Pharmaceuticals Global Market Briefing 2023
... drugs was the largest segment within the pharmaceuticals market accounting for 15.5% followed by oncology drugs at 13.9% and central nervous system drugs at 11.2%. Pharmaceuticals Global Market Briefing 2023 provides strategists, marketers and senior ... Read More
-
Oncology Drugs Global Market Briefing 2023
... market was $28.5 and in terms of global GDP, the market was 0.20%. Oncology drugs was the second largest segment within the market accounting for 13.9% preceded and followed by anti-infective drugs at 15.5% and ... Read More
-
Cardiovascular Drugs Global Market Briefing 2023
... market was $19.8 and in terms of global GDP, the market was 0.14%. Cardiovascular drugs was the fifth largest segment within the market accounting for 9.6% preceded and followed by respiratory diseases drugs at 9.7% ... Read More
-
Metabolic Disorders Drugs Global Market Briefing 2023
... consumption, the market was $11.7 and in terms of global GDP, the market was 0.08%. Metabolic disorders drugs was the seventh largest segment within the market accounting for 5.7% preceded and followed by musculoskeletal disorders ... Read More
-
Anti-Infective Drugs Global Market Briefing 2023
... was $31.8 and in terms of global GDP, the market was 0.23%. Anti-infective drugs was the largest segment within the market accounting for 15.5% followed by oncology drugs at 13.9% and central nervous system drugs ... Read More
-
Genito-Urinary Drugs Global Market Briefing 2023
... market was $5.5 and in terms of global GDP, the market was 0.04%. Genito-urinary drugs was the eleventh largest segment within the market accounting for 2.6% preceded and followed by dermatology drugs at 3.4% and ... Read More
-
Respiratory Diseases Drugs Global Market Briefing 2023
... consumption, the market was $19.8 and in terms of global GDP, the market was 0.14%. Respiratory diseases drugs was the fourth largest segment within the market accounting for 9.7% preceded and followed by central nervous ... Read More
-
Hematology Drugs Global Market Briefing 2023
... market was $4.6 and in terms of global GDP, the market was 0.03%. Hematology drugs was the twelfth largest segment within the market accounting for 2.2% preceded by genito-urinary drugs at 2.6% and dermatology drugs ... Read More
-
Central Nervous System Drugs Global Market Briefing 2023
... per capita consumption, the market was $23.1 and in terms of global GDP, the market was 0.16%. Central nervous system drugs was the third largest segment within the market accounting for 11.2% preceded and followed ... Read More
-
Dermatology Drugs Global Market Briefing 2023
... market was $7.1 and in terms of global GDP, the market was 0.05%. Dermatology drugs was the tenth largest segment within the market accounting for 3.4% preceded and followed by ophthalmology drugs at 3.5% and ... Read More
Research Assistance
